back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-08-14 13:37 Tx date 2024-10-16 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,400
-30,000 vol $0.18 each |
1,343,618 | |
| Filed 2025-08-14 13:30 Tx date 2024-09-03 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,200
-54,000 vol $0.30 each |
1,313,618 | |
| Filed 2025-06-18 16:24 Tx date 2025-06-18 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,425,000 | |
| Filed 2024-12-05 19:32 Tx date 2024-11-26 |
$RP
RepliCel Life Sciences Inc. |
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+295,291 vol |
1,170,923 | |
| Filed 2024-12-05 19:31 Tx date 2024-11-26 |
$RP
RepliCel Life Sciences Inc. |
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Preferred Shares Class A Preference Shares
11 - Acquisition or disposition carried out privately
|
-37,500 vol |
0 | |
| Filed 2024-10-17 17:25 Tx date 2024-10-15 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,000
+60,000 vol $0.05 each |
1,427,618 | |
| Filed 2024-10-17 17:20 Tx date 2024-10-15 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,000
-60,000 vol $0.05 each |
1,025,000 | |
| Filed 2024-09-05 20:11 Tx date 2024-09-03 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
1,085,000 | |
| Filed 2024-04-11 13:06 Tx date 2024-04-01 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-55,000 vol |
835,000 | |
| Filed 2023-05-16 16:26 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
890,000 | |
| Filed 2023-05-10 11:53 Tx date 2023-05-08 |
$RP
RepliCel Life Sciences Inc. |
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
650,000 | |
| Filed 2023-03-01 13:39 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$60,000
+600,000 vol $0.10 each |
1,367,618 | |
| Filed 2023-03-01 13:37 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$60,000
+600,000 vol $0.10 each |
||
| Filed 2022-12-09 14:21 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$60,000
+600,000 vol $0.10 each |
||
| Filed 2023-02-01 19:00 Tx date 2023-02-01 |
$RP
RepliCel Life Sciences Inc. |
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,837
+17,500 vol $0.105 each |
875,632 | |
| Filed 2023-01-30 19:49 Tx date 2021-11-07 |
$RP
RepliCel Life Sciences Inc. |
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-75,000 vol |
250,000 | |
| Filed 2023-01-30 19:46 Tx date 2023-01-26 |
$RP
RepliCel Life Sciences Inc. |
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
550,000 | |
| Filed 2023-01-17 17:55 Tx date 2023-01-17 |
$RP
RepliCel Life Sciences Inc. |
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$37,999
+422,222 vol $0.09 each |
858,132 | |
| Filed 2022-12-09 14:21 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$60,000
+600,000 vol $0.10 each |
1,240,000 | |
| Filed 2022-12-09 14:16 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-60,000
-600,000 vol $0.10 each |
640,000 |